Vascular thrombogenicity induced by progressive LDL oxidation: Protection by antioxidants

Cristina Banfi, Marina Camera, Giovanna Giandomenico, Vincenzo Toschi, Magda Arpaia, Luciana Mussoni, Elena Tremoli, Susanna Colli

Research output: Contribution to journalArticle

Abstract

Oxidative modification of LDL, which dysregulates the homeostasis between blood and vascular cells, and alterations of endothelial function are considered among the early events in the pathogenesis of atherosclerosis. This study was designed to evaluate the impact of progressive LDL oxidation on the thrombotic response both in vitro and in vivo, and to address the potential effect of antioxidants. Tissue factor was induced by progressive LDL oxidation in HUVEC, and this event was in parallel to the appearance of the apoptotic phenotype. Both these phenomena were mediated by ERK 1/2 activation and were prevented by LDL pre-enrichment with antioxidants. In contrast, antioxidants failed to affect tPA and PAI-I secretion, which was increased by LDL, either native or oxidized. Tissue factor-pathway inhibitor was also increased upon HUVEC exposure to progressively oxidized LDL. LDL, in the presence of an oxidative agent, trigger a thrombogenic response in vivo, mostly TF-dependent, in an in situ model of platelet deposition. This effect was markedly attenuated when LDL were enriched with antioxidants. It can be concluded that vascular thrombogenicity is induced by progressive LDL oxidation and that alterations of the antioxidant/oxidant balance of the LDL particle in favor of the antioxidant tone are protective against the thrombotic response triggered by oxidative stress. The extrapolation of these data in a clinical setting, even if not easy, offers potential insights for the use of antioxidants in the prevention of thrombotic complications associated with atherothrombosis.

Original languageEnglish
Pages (from-to)544-553
Number of pages10
JournalThrombosis and Haemostasis
Volume89
Issue number3
Publication statusPublished - Mar 1 2003

Fingerprint

Blood Vessels
Antioxidants
Thromboplastin
oxidized low density lipoprotein
Oxidants
Blood Cells
Atherosclerosis
Oxidative Stress
Homeostasis
Blood Platelets
Phenotype
low density lipoprotein inhibitor

Keywords

  • Antioxidants
  • Endothelial cells
  • Fibrinolysis
  • LDL oxidation
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Banfi, C., Camera, M., Giandomenico, G., Toschi, V., Arpaia, M., Mussoni, L., ... Colli, S. (2003). Vascular thrombogenicity induced by progressive LDL oxidation: Protection by antioxidants. Thrombosis and Haemostasis, 89(3), 544-553.

Vascular thrombogenicity induced by progressive LDL oxidation : Protection by antioxidants. / Banfi, Cristina; Camera, Marina; Giandomenico, Giovanna; Toschi, Vincenzo; Arpaia, Magda; Mussoni, Luciana; Tremoli, Elena; Colli, Susanna.

In: Thrombosis and Haemostasis, Vol. 89, No. 3, 01.03.2003, p. 544-553.

Research output: Contribution to journalArticle

Banfi, C, Camera, M, Giandomenico, G, Toschi, V, Arpaia, M, Mussoni, L, Tremoli, E & Colli, S 2003, 'Vascular thrombogenicity induced by progressive LDL oxidation: Protection by antioxidants', Thrombosis and Haemostasis, vol. 89, no. 3, pp. 544-553.
Banfi, Cristina ; Camera, Marina ; Giandomenico, Giovanna ; Toschi, Vincenzo ; Arpaia, Magda ; Mussoni, Luciana ; Tremoli, Elena ; Colli, Susanna. / Vascular thrombogenicity induced by progressive LDL oxidation : Protection by antioxidants. In: Thrombosis and Haemostasis. 2003 ; Vol. 89, No. 3. pp. 544-553.
@article{6cf6d282c2ad4d9c9cceccc2e6f9af10,
title = "Vascular thrombogenicity induced by progressive LDL oxidation: Protection by antioxidants",
abstract = "Oxidative modification of LDL, which dysregulates the homeostasis between blood and vascular cells, and alterations of endothelial function are considered among the early events in the pathogenesis of atherosclerosis. This study was designed to evaluate the impact of progressive LDL oxidation on the thrombotic response both in vitro and in vivo, and to address the potential effect of antioxidants. Tissue factor was induced by progressive LDL oxidation in HUVEC, and this event was in parallel to the appearance of the apoptotic phenotype. Both these phenomena were mediated by ERK 1/2 activation and were prevented by LDL pre-enrichment with antioxidants. In contrast, antioxidants failed to affect tPA and PAI-I secretion, which was increased by LDL, either native or oxidized. Tissue factor-pathway inhibitor was also increased upon HUVEC exposure to progressively oxidized LDL. LDL, in the presence of an oxidative agent, trigger a thrombogenic response in vivo, mostly TF-dependent, in an in situ model of platelet deposition. This effect was markedly attenuated when LDL were enriched with antioxidants. It can be concluded that vascular thrombogenicity is induced by progressive LDL oxidation and that alterations of the antioxidant/oxidant balance of the LDL particle in favor of the antioxidant tone are protective against the thrombotic response triggered by oxidative stress. The extrapolation of these data in a clinical setting, even if not easy, offers potential insights for the use of antioxidants in the prevention of thrombotic complications associated with atherothrombosis.",
keywords = "Antioxidants, Endothelial cells, Fibrinolysis, LDL oxidation, Thrombosis",
author = "Cristina Banfi and Marina Camera and Giovanna Giandomenico and Vincenzo Toschi and Magda Arpaia and Luciana Mussoni and Elena Tremoli and Susanna Colli",
year = "2003",
month = "3",
day = "1",
language = "English",
volume = "89",
pages = "544--553",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - Vascular thrombogenicity induced by progressive LDL oxidation

T2 - Protection by antioxidants

AU - Banfi, Cristina

AU - Camera, Marina

AU - Giandomenico, Giovanna

AU - Toschi, Vincenzo

AU - Arpaia, Magda

AU - Mussoni, Luciana

AU - Tremoli, Elena

AU - Colli, Susanna

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Oxidative modification of LDL, which dysregulates the homeostasis between blood and vascular cells, and alterations of endothelial function are considered among the early events in the pathogenesis of atherosclerosis. This study was designed to evaluate the impact of progressive LDL oxidation on the thrombotic response both in vitro and in vivo, and to address the potential effect of antioxidants. Tissue factor was induced by progressive LDL oxidation in HUVEC, and this event was in parallel to the appearance of the apoptotic phenotype. Both these phenomena were mediated by ERK 1/2 activation and were prevented by LDL pre-enrichment with antioxidants. In contrast, antioxidants failed to affect tPA and PAI-I secretion, which was increased by LDL, either native or oxidized. Tissue factor-pathway inhibitor was also increased upon HUVEC exposure to progressively oxidized LDL. LDL, in the presence of an oxidative agent, trigger a thrombogenic response in vivo, mostly TF-dependent, in an in situ model of platelet deposition. This effect was markedly attenuated when LDL were enriched with antioxidants. It can be concluded that vascular thrombogenicity is induced by progressive LDL oxidation and that alterations of the antioxidant/oxidant balance of the LDL particle in favor of the antioxidant tone are protective against the thrombotic response triggered by oxidative stress. The extrapolation of these data in a clinical setting, even if not easy, offers potential insights for the use of antioxidants in the prevention of thrombotic complications associated with atherothrombosis.

AB - Oxidative modification of LDL, which dysregulates the homeostasis between blood and vascular cells, and alterations of endothelial function are considered among the early events in the pathogenesis of atherosclerosis. This study was designed to evaluate the impact of progressive LDL oxidation on the thrombotic response both in vitro and in vivo, and to address the potential effect of antioxidants. Tissue factor was induced by progressive LDL oxidation in HUVEC, and this event was in parallel to the appearance of the apoptotic phenotype. Both these phenomena were mediated by ERK 1/2 activation and were prevented by LDL pre-enrichment with antioxidants. In contrast, antioxidants failed to affect tPA and PAI-I secretion, which was increased by LDL, either native or oxidized. Tissue factor-pathway inhibitor was also increased upon HUVEC exposure to progressively oxidized LDL. LDL, in the presence of an oxidative agent, trigger a thrombogenic response in vivo, mostly TF-dependent, in an in situ model of platelet deposition. This effect was markedly attenuated when LDL were enriched with antioxidants. It can be concluded that vascular thrombogenicity is induced by progressive LDL oxidation and that alterations of the antioxidant/oxidant balance of the LDL particle in favor of the antioxidant tone are protective against the thrombotic response triggered by oxidative stress. The extrapolation of these data in a clinical setting, even if not easy, offers potential insights for the use of antioxidants in the prevention of thrombotic complications associated with atherothrombosis.

KW - Antioxidants

KW - Endothelial cells

KW - Fibrinolysis

KW - LDL oxidation

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0037340320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037340320&partnerID=8YFLogxK

M3 - Article

C2 - 12624640

AN - SCOPUS:0037340320

VL - 89

SP - 544

EP - 553

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -